Ipamorelin
Ipamorelin is a selective growth hormone secretagogue (GHS) and ghrelin receptor agonist under investigation for potential research applications in neuroendocrine signaling, cellular growth mechanics, and gastrointestinal motility. This agent, known for its highly targeted ability to stimulate growth hormone release without significantly affecting cortisol or prolactin levels, has garnered attention in academic and pharmaceutical circles due to its promising effects on somatotroph activation, nitrogen retention, and bone mineral density dynamics.
Disclaimer
This information is provided for research and academic purposes only. Ipamorelin is an investigational compound not yet approved for human or animal therapeutic use. The following statements apply to all products offered in this research context: For research use only. Not for human or animal consumption. Users must adhere to all applicable regulatory guidelines and ethical standards governing research compound materials.








Reviews
There are no reviews yet.